Neovue Co., Ltd.
KKRX:0218L011,850.00
KRW
-50.00
(-0.42%)
ISIN
KR70218L0007
Return %
Stock
S&P 500
1Y
- -
13.14
3Y
- -
80.78
5Y
- -
67.74
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- CEO
- Hee-Jo Ha
- Sector
- Producer manufacturing
- Industry
- Auto parts: OEM
- Address
- Anyang-si South Korea
- Website
- neovue.com
- Similar Companies
- Business
- Neovue Co., Ltd. is a South Korea-based medical technology company that specializes in the design, development, and manufacture of advanced ophthalmic medical devices and diagnostic optometry equipment. Founded in 2011 and headquartered in Gyeonggi-do, South Korea, the company operates within the precision medical instruments industry, providing integrated vision care solutions to ophthalmology clinics, hospitals, optometry centers, optical retail chains, and medical research institutions worldwide. Neovue Co., Ltd. categorizes its core business operations into ophthalmic diagnostic instruments, refractive examination systems, and optical measurement equipment. The company's primary product portfolio includes automatic refractors and keratometers for measuring refractive errors and corneal curvature; digital automatic phoropters and computerized refraction systems for subjective visual acuity assessment; digital slit lamps equipped with high-resolution imaging sensors for anterior segment ocular examination; automated lensmeters for optical power, cylinder, axis, and ultraviolet transmittance verification; digital visual acuity chart projectors and polarizing LCD test charts; motorized ophthalmic examination tables; and integrated eye clinic management software platforms. In addition to proprietary finished diagnostic systems, the company provides original equipment manufacturing (OEM) and original design manufacturing (ODM) engineering services, optical component fabrication, calibration, maintenance, and technical training support. Neovue Co., Ltd. distributes its products across domestic and international markets, spanning the Asia-Pacific region, Europe, North America, the Middle East, and Latin America through a global network of specialized medical distribution partners. In recent major company developments, Neovue Co., Ltd. has expanded its technological capabilities through the commercial launch of next-generation artificial intelligence-driven diagnostic imaging software designed to enhance automatic lesion detection and ocular parameter analysis. The company has also established strategic international distribution agreements across European and Southeast Asian markets, secured upgraded international medical device quality standard certifications under ISO 13485 and Medical Device Regulation (MDR) frameworks, and expanded its precision manufacturing facilities to scale production capacity for its smart digital refraction workstations and cloud-connected ophthalmic diagnostic product lines.